Alzheimer’s and Parkinson’s Disease Conference 2022 – Eisai/Biogen Latest Data
Michael Irizarry, MD, MPH, Senior Vice President, Clinical Research and Deputy Chief Clinical Officer of the Neurology Business Group at Eisai Inc.
5304 articles
Michael Irizarry, MD, MPH, Senior Vice President, Clinical Research and Deputy Chief Clinical Officer of the Neurology Business Group at Eisai Inc.
Rajasi Mills, VP of Sleep IQ Health at Sleep Number, the smart bed company committed to advancing sleep health and connecting the dots between quality s...
Suneet Grewal, MD, a rheumatologist at East Bay Rheumatology Medical Group in the Bay Area discusses the supplemental Biologics License Application (sBL...
Robert Hummel, Chief Operating Officer at Suvoda, a global clinical trial technology company, discusses the rise in trial complexity, how the focus has ...
Eric Brouwer, Ph.D., Chief Scientific Officer at SQI Diagnostics, a company focused on the science of lung health, discusses the development and manufac...
Jeffrey Dlott, Medical Director at Quest Direct discusses the new "Future of Personalized Healthcare Insights Study 2022" that was conducted by Leaf Gro...
Mark Berman, Chief Medical Officer of Better Therapeutics discusses how prescription digital therapeutics (PDTs) could reimagine how we treat type 2 dia...
Tony Mack, Chairman and CEO of Virpax Pharma, discusses a new drug candidate in the pipeline that uses the Intranasal MET-nanoparticle dispersion deli...
Telehealth at UpHealth and founder of Martti™ by UpHealth, a telehealth platform that includes language access discusses how language barriers affe...
Angela Carroll, US Medical Affairs Scientific Director-Immuno-inflammation at GlaxoSmithKline (GSK), a global health care company, discusses...